Wearable Physiology Monitoring Company Biovotion Holds First Close of CHF10M Series A Funding

biovotionBiovotion Ltd, a Zurich, Switzerland-based wearable physiology monitoring company, held the first closing of its ongoing CHF10M Series A financing round.

The round is led by Swiss Re (Ticker symbol: SREN) with participation from existing investor STMicroelectronics NV (EPA: STM).

The company, which is now in the process to add further strategically instrumental partners in a second closing of this Series A round, intends to use the funds to prepare the introduction of its platform in the medical markets.

Founded in 2011 by Dr. Andreas Caduff, CEO, Biovotion provides clinical-grade wearable solutions based on the company’s know-how and IP in non-invasive physiological monitoring, including vital sign, hydration, and glucose monitoring, supporting users in keeping a healthy lifestyle, improving healthcare treatment outcomes, and aiming to reduce cost of health provisions.



Join the discussion